Table of Contents Author Guidelines Submit a Manuscript
Disease Markers
Volume 2016, Article ID 5423043, 5 pages
Research Article

The Role of Fecal Calprotectin in Evaluating Intestinal Involvement of Behçet’s Disease

1Division of Gastroenterology, Department of Internal Medicine, School of Medicine, Muğla Sıtkı Koçman University, 48000 Muğla, Turkey
2Department of Internal Medicine, School of Medicine, Muğla Sıtkı Koçman University, 48000 Muğla, Turkey
3Department of Pathology, Education and Research Hospital, Muğla Sıtkı Koçman University, 48000 Muğla, Turkey
4Gastroenterology Unit, Batman State Hospital, 72070 Batman, Turkey
5Department of Internal Medicine, Division of Gastroenterology, School of Medicine, Hacettepe University, 06230 Ankara, Turkey

Received 28 January 2016; Revised 31 May 2016; Accepted 2 June 2016

Academic Editor: Paul Ashwood

Copyright © 2016 Burak Özşeker et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


One of the regions of involvement of Behçet’s disease (BD), a systematic inflammatory vasculitis with unknown etiology, is the gastrointestinal (GI) tract. Upper GI endoscopy, colonoscopy, and capsule endoscopy are frequently used methods to diagnose the intestinal involvement of BD. The aim of this study was to investigate the role of fecal calprotectin (FC) in the evaluation of intestinal involvement in BD. Material and Method. A total of 30 patients who were diagnosed with BD and had no GI symptoms and 25 individuals in the control group were included in this study. Results. Levels of FC were statistically significantly higher in patients with BD compared to the control group (). The correlation analysis performed including FC and markers of disease activity revealed a positive and statistically significant correlation between FC level and CRP and erythrocyte sedimentation rate (: 0.255, , and : 0.404, , resp.). FC levels in patients who were detected to have ulcers in the terminal ileum and colon in the colonoscopic examination were statistically significantly higher compared to the patients with BD without intestinal involvement (). Conclusion. The measurement of FC levels, in patients with BD who are asymptomatic for GI involvement, may be helpful to detect the possible underlying intestinal involvement.